349
Views
36
CrossRef citations to date
0
Altmetric
Original Research

A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles

, &
Pages 3365-3382 | Published online: 02 Sep 2013

References

  • ChenXSchluesenerHJNanosilver: a nanoproduct in medical applicationToxicol Lett2008176111218022772
  • HollerJSNordbergGFFowlerBASilverNordbergGFFowlerBANordbergMFribergLTHandbook on the Toxicology of Metals3rd edBurlingtonAcademic Press2007809814
  • FoxCLSilver sulfadiazine – a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burnsArch Surg19689621841885638080
  • YinHQLangfordRBurrellREComparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressingJ Burn Care Rehabil199920319520010342470
  • ChaloupkaKMalamYSeifalianAMNanosilver as a new generation of nanoproduct in biomedical applicationsTrends Biotechnol2010281158058820724010
  • QuadrosMEMarrLCSilver nanoparticles and total aerosols emitted by nanotechnology-related consumer spray productsEnviron Sci Technol20114524107131071922070550
  • LorenzCWindlerLvon GoetzNCharacterization of silver release from commercially available functional (nano)textilesChemosphere201289781782422677521
  • von GoetzNFabriciusLGlausRWeitbrechtVGüntherDHungerbühlerKMigration of silver from commercial plastic food containers and implications for consumer exposure assessmentFood Addit Contam Part A Chem Anal Control Expo Risk Assess201330361262023406534
  • WijnhovenSWPPeijnenburgWJGMHerbertsCANano-silver: a review of available data and knowledge gaps in human and environmental risk assessmentNanotoxicology200932109138
  • Project on Emerging Nanotechnologies [homepage on the Internet]Consumer product analysis [updated March 14, 2011] Available from: http://www.nanotechproject.org/inventories/consumer/analysis_draft/Accessed March 21, 2013
  • WadheraAFungMSystemic argyria associated with ingestion of colloidal silverDermatol Online J20051111215748553
  • ChangALKhosraviVEgbertBA case of argyria after colloidal silver ingestionJ Cutan Pathol2006331280981117177941
  • Fairvital [homepage on the Internet]Colloidales silber 15 ml 500 ppm non-ionic [updated not specified] Available from: http://www.fairvital.com/product_info.php?products_id=77Accessed March 21, 2013
  • US Public Health ServiceATSDR Toxicological profile for silverAtlantaAgency for Toxic Substances and Disease Registry1990 Available from: http://www.atsdr.cdc.gov/toxprofiles/tp146.pdfAccessed June 17, 2013
  • GaulLEStaudAHClinical spectroscopy: seventy cases of generalized argyrosis following organic and colloidal silver medication, including a biospectrometric analysis of ten casesJAMA19351041613871390
  • PalaGFronterréAScafaFOcular argyrosis in a silver craftsmanJ Occup Health200850652152418971576
  • RosemaryJ [homepage on the Internet]Rosemary’s story [updated January 22, 2013] Available from: http://www.rosemaryjacobs.comAccessed May 21, 2013
  • KreuterJInfluence of the surface properties on nanoparticle-mediated transport of drugs to the brainJ Nanosci Nanotechnol20044548448815503433
  • TanDXManchesterLCTerronMPFloresLJReiterRJOne molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?J Pineal Res2007421284217198536
  • SiesHOxidative stress: oxidants and antioxidantsExp Physiol19978222912959129943
  • ChristensenFMJohnstonHJStoneVNano-silver – feasibility and challenges for human health risk assessment based on open literatureNanotoxicology20104328429520795910
  • IPCSThe harmonization project document series no 9: Guidance on principles of characterizing and applying PBPK models in risk assessmentWHO Library Cataloguing-in-Publication Data: International Programme on Chemical Safety2010
  • ReddyMBYangRSHClewellHJIIIAndersenMEPhysiologically based pharmacokinetic modeling: Science and applicationsHobokenJohn Wiley & Sons2005
  • PéryARBrochotCHoetPHNemmarABoisFYDevelopment of a physiologically based kinetic model for 99m-technetium-labelled carbon nanoparticles inhaled by humansInhal Toxicol200921131099110719814607
  • LiMPanagiZAvgoustakisKReinekeJPhysiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG contentInt J Nanomedicine201271345135622419876
  • LankveldDPOomenAGKrystekPThe kinetics of the tissue distribution of silver nanoparticles of different sizesBiomaterials201031328350836120684985
  • LeeHALeavensTLMasonSEMonteiro-RiviereNARiviereJEComparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic modelNano Lett20099279479919128005
  • KlaassenCDBiliary excretion of silver in the rat, rabbit, and dogToxicol Appl Pharmacol19795014955494300
  • ICRPBasic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89Ann ICRP2002323–4526514506981
  • SungJHJiJHYoonJULung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticlesInhal Toxicol200820656757418444009
  • KimYSKimJSChoHSTwenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley ratsInhal Toxicol200820657558318444010
  • XueYZhangSHuangYAcute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in miceJ Appl Toxicol2012321189089922522906
  • KimWYKimJParkJDRyuHYYuIJHistological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 ratsJ Toxicol Environ Health Part A20097221–221279128420077197
  • ECHAGuidance on information requirements and chemical safety assessment: Chapter R15: Consumer exposure estimationHelsinkiEuropean Chemicals Agency2010
  • ICRPHuman respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological ProtectionAnn ICRP1994241–31482
  • TakenakaSKargERothCPulmonary and systemic distribution of inhaled ultrafine silver particles in ratsEnviron Health Perspect2001109Suppl 454755111544161
  • HansenRERothDWintherJRQuantifying the global cellular thiol-disulfide statusProc Natl Acad Sci U S A2009106242242719122143
  • IsabAAWazeerMISynthesis and characterization of thiolate-Ag(I) complexes by solid-state and solution NMR and their antimicrobial activitySpectrochim Acta A Mol Biomol Spectrosc200766236437016843708
  • BellRAKramerJRStructural chemistry and geochemistry of silver-sulfur compounds: Critical reviewEnviron Toxicol Chem1999181922
  • ICRPReport of Committee II on permissible dose for internal radiation (1959)Annals of the ICRP/ICRP Publication19602140
  • BrandenbergerCMühlfeldCAliZQuantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticlesSmall20106151669167820602428
  • SarinHPhysiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJ Angiogenes Res201021420701757
  • DavisSSIllumLMoghimiSMMicrospheres for targeting drugs to specific body sitesJ Control Release1993241–3157163
  • IllumLDavisSSTargeting of colloidal particles to the bone marrowLife Sci19874016155315603561165
  • DaldrupHELinkTMBlasiusSMonitoring radiation-induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRIJ Magn Reson Imaging19999564365210331759
  • van FurthRCohnZAHirschJGHumphreyJHSpectorWGLangevoortHLThe mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cellsBull World Health Organ19724668458524538544
  • ChampionJAWalkerAMitragotriSRole of particle size in phagocytosis of polymeric microspheresPharm Res20082581815182118373181
  • DoshiNMitragotriSMacrophages recognize size and shape of their targetsPLoS One201054e1005120386614
  • LoeschnerKHadrupNQvortrupKDistribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetatePart Fibre Toxicol201181821631937
  • van der ZandeMVandebrielRJVan DorenEDistribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposureACS Nano2012687427744222857815
  • GettlerAORhoadsCPWeissSA Contribution to the Pathology of Generalized Argyria with a Discussion of the Fate of Silver in the Human BodyAm J Pathol192736631652.1519969770
  • EastBWBoddyKWilliamsEDMacintyreDMclayALSilver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetateClin Exp Dermatol1980533053117438526
  • FurchnerJERichmondCRDrakeGAComparative metabolism of radionuclides in mammals-IV. Retention of silver-110m in the mouse, rat, monkey, and dogHealth Phys19681565055144972147
  • LiuJPennellKGHurtRHKinetics and mechanisms of nanosilver oxysulfidationEnviron Sci Technol201145177345735321770469
  • LiuJSonshineDAShervaniSHurtRHControlled release of biologically active silver from nanosilver surfacesACS Nano20104116903691320968290
  • WöblingRHWilbradtRSchopenhauer-GermannEEulerGKönigKHArgyrose bei Beschäftigten in der silberverarbeitenden Industrie: Dermatologische Untersuchungen und quantitative Messungen mittels Atomabsorptionsspektrometrie [Argyrosis among workers in the silver industry: dermatological examinations and quantitative measurements by atomic absorption spectrometry]Arbeitsmed Sozialmed Praventivmed198823293297 German
  • DanscherGLight and electron microscopic localization of silver in biological tissueHistochemistry19817121771867239944
  • TriebigGValentinHBerufskrankheit Argyrose? – Aktuelle Aspekte [Occupational disease argyrosis? – Current aspects]Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin198222239243 German
  • AlexanderJAasethJHepatobiliary transport and organ distribution of silver in the rat as influenced by seleniteToxicology19812131791867292506
  • BallatoriNClarksonTWBiliary secretion of glutathione and of glutathione-metal complexesFundam Appl Toxicol1985558168314065458
  • PerrelliGPiolattoGTentative reference values for gold, silver and platinum: literature data analysisSci Total Environ19921201–293961641644
  • von GoetzNLorenzCWindlerLNowackBHeubergerMHungerbühlerKMigration of Ag- and TiO2-nanoparticles from textiles into artificial sweat under physical stress: Experiments and exposure modelingEnviron Sci Technol In press2013
  • DiVincenzoGDGiordanoCJSchrieverLSBiologic monitoring of workers exposed to silverInt Arch Occup Environ Health19855632072154066049
  • WalczakAPFokkinkRPetersRBehaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion modelNanotoxicology Epub2012101
  • JiJHJungJHKimSSTwenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley ratsInhal Toxicol2007191085787117687717
  • ParkKParkEJChunIKBioavailability and toxicokinetics of citrate-coated silver nanoparticles in ratsArch Pharm Res201134115315821468927
  • HirnSSemmler-BehnkeMSchlehCParticle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEur J Pharm Biopharm201177340741621195759
  • DziendzikowskaKGromadzka-OstrowskaJLankoffATime-dependent biodistribution and excretion of silver nanoparticles in male Wistar ratsJ Appl Toxicol2012321192092822696427
  • BaderKFOrgan deposition of silver following silver nitrate therapy of burnsPlast Reconstr Surg19663765505515932415
  • LeeJHMunJParkJDYuIJA health surveillance case study on workers who manufacture silver nanomaterialsNanotoxicology20126666766921777050
  • WangJZhouGChenCAcute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administrationToxicol Lett2007168217618517197136
  • GreulichCKittlerSEppleMMuhrGKöllerMStudies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs)Langenbecks Arch Surg2009394349550219280220
  • FoldbjergRDangDAAutrupHCytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549Arch Toxicol201185774375020428844
  • FoldbjergROlesenPHougaardMDangDAHoffmannHJAutrupHPVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytesToxicol Lett2009190215616219607894
  • GreulichCBraunDPeetschAThe toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration rangeRSC Advances201221769816987
  • HadrupNLoeschnerKMortensenAThe similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitroNeurotoxicology201233341642322531227
  • HackenbergSScherzedAKesslerMSilver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cellsToxicol Lett20112011273321145381
  • SambergMEOldenburgSJMonteiro-RiviereNAEvaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitroEnviron Health Perspect2010118340741320064793
  • US-EPA [homepage on the Internet]Integrated risk information system – silver (CASRN 7440-22-4) [updated January 12, 1996] Available from: http://www.epa.gov/iris/subst/0099.htmAccessed March 21, 2013
  • BouwmeesterHPoortmanJPetersRJCharacterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture modelACS Nano2011554091410321480625
  • LandsiedelRFabianEMa-HockLToxico-/biokinetics of nanomaterialsArch Toxicol20128671021106022576463
  • MacCuspieRIColloidal stability of silver nanoparticles in biologically relevant conditionsJ Nanopart Res201113728932908
  • MacCuspieRIAllenAJHackleyVADispersion stabilization of silver nanoparticles in synthetic lung fluid studied under in situ conditionsNanotoxicology20115214015621609136
  • GöppertTMMüllerRHPolysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patternsJ Drug Target200513317918716036306
  • WasdoSCBarberDSDenslowNDDifferential binding of serum proteins to nanoparticlesInt J Nanotechnol20085192115
  • LiYPeiYZhangXPEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsJ Control Release200171220321111274752
  • RejmanJOberleVZuhornISHoekstraDSize-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosisBiochem J2004377Pt 115916914505488
  • ChoiHSLiuWMisraPRenal clearance of quantum dotsNat Biotechnol200725101165117017891134
  • ChenJTanMNemmarAQuantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharideToxicology2006222319520116584826
  • SakaiNTakakuraMImamuraHWhole-body distribution of C-14-labeled silica nanoparticles and submicron particles after intravenous injection into miceJ Nanopart Res201214511122448125
  • ParkEJBaeEYiJRepeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticlesEnviron Toxicol Pharmacol201030216216821787647
  • KreylingWGSemmler-BehnkeMSeitzJSize dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organsInhal Toxicol200921Suppl 1556019558234
  • Garza-OcañasLFerrerDABurtJBiodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in ratsMetallomics20102320421021069158
  • JiangJKOberdorsterGBiswasPCharacterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studiesJ Nanopart Res20091117789
  • Semmler-BehnkeMKreylingWGLipkaJBiodistribution of 1.4- and 18-nm gold particles in ratsSmall20084122108211119031432
  • LochtLJLarsenAStoltenbergMDanscherGCultured macrophages cause dissolucytosis of metallic silverHistol Histopathol200924216717319085833
  • LochtLJSmidtKRungbyJStoltenbergMLarsenAUptake of silver from metallic silver surfaces induces cell death and a pro-inflammatory response in cultured J774 macrophagesHistol Histopathol201126668969721472684
  • ScroggsMWLewisJSProiaADCorneal argyrosis associated with silver solderingCornea19921132642691587137
  • WangXQChangHEFrancisRSilver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressingJ Cutan Pathol200936778879219519610
  • LevardCReinschBCMichelFMOumahiCLowryGVBrownGESulfidation processes of PVP-coated silver nanoparticles in aqueous solution: impact on dissolution rateEnviron Sci Technol201145125260526621598969
  • LevardCHotzeEMLowryGVBrownGEEnvironmental transformations of silver nanoparticles: impact on stability and toxicityEnviron Sci Technol201246136900691422339502
  • BlumbergHCareyTNArgyremia: Detection of unsuspected and obscure argyria by the spectrographic demonstration of high blood silverJAMA19341032015211524
  • DrakePLHazelwoodKJExposure-related health effects of silver and silver compounds: a reviewAnn Occup Hyg200549757558515964881
  • BachandGAllenABachandMAchyuthanKSeagraveJBrozikSCytotoxicity and inflammation in human alveolar epithelial cells following exposure to occupational levels of gold and silver nanoparticlesJ Nanopart Res2012141011022448125
  • VogtACombadiereBHadamS40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skinJ Invest Dermatol200612661316132216614727
  • TanMHCommensCABurnettLSnitchPJA pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreensAustralas J Dermatol19963741851878961584